The PI3K‐Akt pathway has been abnormally activated in several malignancies, including ccRCC, gastric tumors, lung tumors, and carcinoma of the prostate [17, 18, 19, 20]. The gene discussed is PIK3CG; the disease is nonpapillary renal cell carcinoma.